LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article ; Online: Anastomotic leakage following resection of the esophagus-introduction of an endoscopic grading system.

    Bachmann, Jeannine / Feith, Marcus / Schlag, Christoph / Abdelhafez, Mohamed / Martignoni, Marc E / Friess, Helmut

    World journal of surgical oncology

    2022  Volume 20, Issue 1, Page(s) 104

    Abstract: Background: Malignant tumors of the esophagus are the sixth leading cause of cancer-related deaths worldwide. Postoperative leakage of the esophago-gastrostomy leads to mediastinal sepsis, which is still associated with a high morbidity and mortality ... ...

    Abstract Background: Malignant tumors of the esophagus are the sixth leading cause of cancer-related deaths worldwide. Postoperative leakage of the esophago-gastrostomy leads to mediastinal sepsis, which is still associated with a high morbidity and mortality rate. The aim of this study was to describe the endoscopic view of the different severity grades of an anastomotic leakage.
    Methods: Patients Between June 2016 and September 2018, 144 patients were operated upon in the Department of Surgery, University of Munich, Germany. Among these patients, 34 (23.6%) presented with a leakage of the anastomosis. Endoscopy In this retrospective analysis, the focus is to describe different patterns of leakage of the anastomosis.
    Results: We studied 34 patients in whom post-esophagectomy leakage of the anastomosis was detected and treated with an endoluminal vacuum sponge system. The leakage healed in 26 of 29 patients (success rate 89.7%). With the increasing severity of leakage, the treatment time and the in-hospital mortality correspondingly increased. Furthermore, the incidence of the development of a fistula to the tracheobronchial system increased with higher grades of leakage.
    Conclusions: Exact descriptions of leakage are necessary to compare the cases and to prove post-treatment improvement. This is, to our knowledge, the first publication to present a leakage grading score in patients after esophagectomy including reconstruction with a gastric tube. This new grading system needs to be tested in further analyses, with a special focus on prospective analysis.
    MeSH term(s) Anastomotic Leak/etiology ; Endoscopy, Gastrointestinal ; Esophagectomy/adverse effects ; Esophagus/surgery ; Humans ; Retrospective Studies
    Language English
    Publishing date 2022-03-31
    Publishing country England
    Document type Journal Article
    ZDB-ID 2118383-1
    ISSN 1477-7819 ; 1477-7819
    ISSN (online) 1477-7819
    ISSN 1477-7819
    DOI 10.1186/s12957-022-02551-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cancer cachexia.

    Martignoni, Marcus E / Kunze, Philipp / Friess, Helmut

    Molecular cancer

    2003  Volume 2, Page(s) 36

    Abstract: In recent years many efforts of researchers and clinicians were made to improve our knowledge of cachexia syndrome. Not only cancer, but also many chronic or end-stage diseases such as AIDS, chronic obstructive pulmonary disease (COPD), rheumatoid ... ...

    Abstract In recent years many efforts of researchers and clinicians were made to improve our knowledge of cachexia syndrome. Not only cancer, but also many chronic or end-stage diseases such as AIDS, chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, tuberculosis and Crohn's disease are associated with cachexia, a condition of abnormally low weight, weakness, and general bodily decline which deteriorates quality of life and reduces the prognosis of the patients who suffer from it. In the present editorial we will focus cachexia related on cancer and provide some insight into this prognosis-limiting syndrome.
    MeSH term(s) Cachexia/etiology ; Cachexia/therapy ; Humans ; Neoplasms/complications
    Language English
    Publishing date 2003-11-05
    Publishing country England
    Document type Editorial
    ISSN 1476-4598
    ISSN (online) 1476-4598
    DOI 10.1186/1476-4598-2-36
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cancer cachexia

    Kunze Philipp / Martignoni Marcus E / Friess Helmut

    Molecular Cancer, Vol 2, Iss 1, p

    2003  Volume 36

    Abstract: Abstract In recent years many efforts of researchers and clinicians were made to improve our knowledge of cachexia syndrome. Not only cancer, but also many chronic or end-stage diseases such as AIDS, chronic obstructive pulmonary disease (COPD), ... ...

    Abstract Abstract In recent years many efforts of researchers and clinicians were made to improve our knowledge of cachexia syndrome. Not only cancer, but also many chronic or end-stage diseases such as AIDS, chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, tuberculosis and Crohn's disease are associated with cachexia, a condition of abnormally low weight, weakness, and general bodily decline which deteriorates quality of life and reduces the prognosis of the patients who suffer from it. In the present editorial we will focus cachexia related on cancer and provide some insight into this prognosis-limiting syndrome.
    Keywords cachexia ; pancreatic cancer ; cytokines ; Neoplasms. Tumors. Oncology. Including cancer and carcinogens ; RC254-282 ; Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Oncology ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
    Language English
    Publishing date 2003-11-01T00:00:00Z
    Publisher BioMed Central
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Cachexia in patients with chronic pancreatitis and pancreatic cancer: impact on survival and outcome.

    Bachmann, Jeannine / Büchler, Markus W / Friess, Helmut / Martignoni, Marc E

    Nutrition and cancer

    2013  Volume 65, Issue 6, Page(s) 827–833

    Abstract: Chronic pancreatitis (CP) and pancreatic adenocarcinoma (PDAC) are the most common diseases of the pancreas. Cachexia-weight loss exceeding 10% of stable body weight-is present in up to 80% of patients with PDAC. Because the mechanisms of cachexia are ... ...

    Abstract Chronic pancreatitis (CP) and pancreatic adenocarcinoma (PDAC) are the most common diseases of the pancreas. Cachexia-weight loss exceeding 10% of stable body weight-is present in up to 80% of patients with PDAC. Because the mechanisms of cachexia are not well known, this provides a possibility to compare clinical courses of benign and malignant cachexia. In this study, 382 patients-242 with a PDAC stage UICC II/ 140 with CP-were documented regarding the prevalence of cachexia and its influence on perioperative morbidity and mortality with a special interest to postoperative weight gain and survival. Cachexia was present in 41.4% of CP and 31% of cancer patients. We could demonstrate more pronounced systemic effects of cachexia in patients with PDAC. Weight loss was faster in PDAC patients, the amount of weight loss did not differ significantly between the groups. Cachexia had a significant impact on survival and the postoperative course in patients with PDAC and tumor resection. The development of cachexia is faster in patients with a malignant disease and the systemic effects are more pronounced. Therefore, tumor cachexia should be considered as a different entity than cachexia in benign diseases.
    MeSH term(s) Adult ; Aged ; Body Mass Index ; Cachexia/mortality ; Cachexia/pathology ; Endpoint Determination ; Female ; Humans ; Male ; Middle Aged ; Morbidity ; Nutritional Status ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; Pancreatitis, Chronic/mortality ; Pancreatitis, Chronic/pathology ; Postoperative Care ; Retrospective Studies ; Survival Rate ; Weight Gain ; Weight Loss
    Language English
    Publishing date 2013
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 424433-3
    ISSN 1532-7914 ; 0163-5581
    ISSN (online) 1532-7914
    ISSN 0163-5581
    DOI 10.1080/01635581.2013.804580
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: First experience with image-guided resection of paraganglioma.

    Einspieler, Ingo / Novotny, Alexander / Okur, Asli / Essler, Markus / Martignoni, Marc E

    Clinical nuclear medicine

    2014  Volume 39, Issue 8, Page(s) e379–81

    Abstract: A 32-year-old male patient showed 2 focal uptakes of I-MIBG next to the left renal vein in a diagnostic scan, corresponding to paragangliomas. An operation was indicated, and to guide resection during surgery we used the freehand SPECT system. In the ... ...

    Abstract A 32-year-old male patient showed 2 focal uptakes of I-MIBG next to the left renal vein in a diagnostic scan, corresponding to paragangliomas. An operation was indicated, and to guide resection during surgery we used the freehand SPECT system. In the operating room, using freehand SPECT, both lesions were found. The system was of additional value in planning the operative access to the region of interest and in determining the depth of 1 lesion for precise and more rapid extirpation. Furthermore, it confirmed no residues in the operating field after resection of the tumors.
    MeSH term(s) 3-Iodobenzylguanidine ; Adult ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/surgery ; Humans ; Male ; Paraganglioma/diagnostic imaging ; Paraganglioma/surgery ; Radiopharmaceuticals ; Surgery, Computer-Assisted/instrumentation ; Surgery, Computer-Assisted/methods ; Tomography, Emission-Computed, Single-Photon
    Chemical Substances Radiopharmaceuticals ; 3-Iodobenzylguanidine (35MRW7B4AD)
    Language English
    Publishing date 2014-08
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 197628-x
    ISSN 1536-0229 ; 0363-9762
    ISSN (online) 1536-0229
    ISSN 0363-9762
    DOI 10.1097/RLU.0000000000000239
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia.

    Schmitt, Thomas L / Martignoni, Marcus E / Bachmann, Jeannine / Fechtner, Kerstin / Friess, Helmut / Kinscherf, Ralf / Hildebrandt, Wulf

    Journal of molecular medicine (Berlin, Germany)

    2007  Volume 85, Issue 6, Page(s) 647–654

    Abstract: In animal models of cachexia, alterations in the phosphatidylinositol 3-kinase (PI3-K)/Akt pathway have been demonstrated in atrophying skeletal muscles. Therefore, we assessed the activity of proteins in this pathway in muscle and liver biopsies from 16 ...

    Abstract In animal models of cachexia, alterations in the phosphatidylinositol 3-kinase (PI3-K)/Akt pathway have been demonstrated in atrophying skeletal muscles. Therefore, we assessed the activity of proteins in this pathway in muscle and liver biopsies from 16 patients undergoing pancreatectomy for suspect of carcinoma. Patients were divided in a non-cachectic or cachectic group according to their weight loss before operation. Extracts of skeletal muscle and liver tissue from eight cachectic patients with pancreas carcinoma and eight non-cachectic patients were analysed by Western blotting using pan- and phospho-specific antibodies directed against eight important signal transduction proteins of the PI3-K/Akt pathway. Muscle samples from cachectic patients revealed significantly decreased levels of myosin heavy chain (-45%) and actin (-18%) in comparison to non-cachectic samples. Akt protein level was decreased by -55%. The abundance and/or phosphorylation of the transcription factors Foxo1 and Foxo3a were reduced by up to fourfold in muscle biopsies from cachectic patients. Various decreases of the phosphorylated forms of the protein kinases mTOR (-82%) and p70S6K (-39%) were found. In contrast to skeletal muscle, cachexia is associated with a significant increase in phosphorylated Akt level in the liver samples with a general activation of the PI3-K/Akt cascade. Our study demonstrates a cachexia-associated loss of Akt-dependent signalling in human skeletal muscle with decreased activity of regulators of protein synthesis and a disinhibition of protein degradation.
    MeSH term(s) Actins/metabolism ; Biopsy ; Cachexia/complications ; Cachexia/enzymology ; Female ; Forkhead Transcription Factors/metabolism ; Humans ; Liver/enzymology ; Male ; Microfilament Proteins/metabolism ; Middle Aged ; Muscles/enzymology ; Myosins/metabolism ; Neoplasms/complications ; Neoplasms/enzymology ; Pancreatitis/enzymology ; Phosphatidylinositol 3-Kinases/metabolism ; Phosphorylation ; Protein Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Ribosomal Protein S6 Kinases, 70-kDa/metabolism ; TOR Serine-Threonine Kinases
    Chemical Substances Actins ; Forkhead Transcription Factors ; Microfilament Proteins ; moesin (144131-77-1) ; Protein Kinases (EC 2.7.-) ; MTOR protein, human (EC 2.7.1.1) ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1) ; Ribosomal Protein S6 Kinases, 70-kDa (EC 2.7.11.1) ; TOR Serine-Threonine Kinases (EC 2.7.11.1) ; Myosins (EC 3.6.4.1)
    Language English
    Publishing date 2007-03-02
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1223802-8
    ISSN 1432-1440 ; 0946-2716
    ISSN (online) 1432-1440
    ISSN 0946-2716
    DOI 10.1007/s00109-007-0177-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.

    Swoboda, Stefanie / Fritz, Stefan / Martignoni, Marcus E / Feldhues, Rita A / Hoppe-Tichy, Torsten / Buchler, Markus W / Geiss, Heinrich K

    The Journal of antimicrobial chemotherapy

    2005  Volume 56, Issue 4, Page(s) 787–789

    Abstract: Objectives: Linezolid is an oxazolidinone antibiotic used in the treatment of infections caused by vancomycin-resistant enterococci. Resistance to linezolid has been associated with a G2576U mutation in domain V of the 23S rRNA.: Patient and methods: ...

    Abstract Objectives: Linezolid is an oxazolidinone antibiotic used in the treatment of infections caused by vancomycin-resistant enterococci. Resistance to linezolid has been associated with a G2576U mutation in domain V of the 23S rRNA.
    Patient and methods: We present clinical details and susceptibility data from multiple Enterococcus faecium strains isolated from a liver transplant patient over 13 months. MICs of linezolid, vancomycin and quinupristin/dalfopristin were determined using Etest. Molecular typing was performed by pulsed-field gel electrophoresis. Domain V of the 23S rRNA gene in the vancomycin-resistant Enterococcus faecium was amplified. Linezolid concentrations were analysed by HPLC.
    Results: We report the emergence of resistance to linezolid in a vancomycin-resistant Enterococcus faecium during linezolid treatment. After discontinuation of the linezolid therapy, the isolate reverted to susceptibility. However, after re-administration of linezolid the vancomycin-resistant Enterococcus faecium became resistant to linezolid again. The isolates that were resistant to linezolid had a G2576T mutation in their 23S rDNA.
    Conclusion: We describe a clinical case that shows the shift of a vancomycin-resistant Enterococcus faecium from linezolid resistance to susceptibility and then back to resistance again related to linezolid therapy.
    MeSH term(s) Acetamides/pharmacology ; Acetamides/therapeutic use ; Adult ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Enterococcus faecium/drug effects ; Enterococcus faecium/genetics ; Gram-Positive Bacterial Infections/drug therapy ; Gram-Positive Bacterial Infections/microbiology ; Humans ; Linezolid ; Liver Transplantation ; Male ; Microbial Sensitivity Tests ; Mutation ; Oxazolidinones/pharmacology ; Oxazolidinones/therapeutic use ; Time Factors ; Vancomycin Resistance ; Virginiamycin/pharmacology
    Chemical Substances Acetamides ; Anti-Bacterial Agents ; Oxazolidinones ; Virginiamycin (11006-76-1) ; quinupristin-dalfopristin (126602-89-9) ; Linezolid (ISQ9I6J12J)
    Language English
    Publishing date 2005-10
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 191709-2
    ISSN 1460-2091 ; 0305-7453
    ISSN (online) 1460-2091
    ISSN 0305-7453
    DOI 10.1093/jac/dki318
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A proposal for a new clinical classification of chronic pancreatitis.

    Büchler, Markus W / Martignoni, Marc E / Friess, Helmut / Malfertheiner, Peter

    BMC gastroenterology

    2009  Volume 9, Page(s) 93

    Abstract: ... criteria are: pain, recurrent attacks of pancreatitis, complications of chronic pancreatitis (e.g ...

    Abstract Background: The clinical course of chronic pancreatitis is still unpredictable, which relates to the lack of the availability of a clinical classification. Therefore, patient populations cannot be compared, the course and the outcome of the disease remain undetermined in the individual patient, and treatment is not standardized.
    Aim: To establish a clinical classification for chronic pancreatitis which is user friendly, transparent, relevant, prognosis- as well as treatment-related and offers a frame for future disease evaluation.
    Methods: Diagnostic requirements will include one clinical criterion, in combination with well defined imaging or functional abnormalities.
    Results: A classification system consisting of three stages (A, B and C) is presented, which fulfils the above-mentioned criteria. Clinical criteria are: pain, recurrent attacks of pancreatitis, complications of chronic pancreatitis (e.g. bile duct stenosis), steatorrhea, and diabetes mellitus. Imaging criteria consist of ductal or parenchymal changes observed by ultrasonography, ERCP, CT, MRI, and/or endosonography.
    Conclusion: A new classification of chronic pancreatitis, based on combination of clinical signs, morphology and function, is presented. It is easy to handle and an instrument to study and to compare the natural course, the prognosis and treatment of patients with chronic pancreatitis.
    MeSH term(s) Cholangiopancreatography, Endoscopic Retrograde ; Cholestasis/etiology ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Pain/etiology ; Pancreas/pathology ; Pancreas/physiopathology ; Pancreatitis, Chronic/classification ; Pancreatitis, Chronic/complications ; Pancreatitis, Chronic/diagnosis ; Prognosis ; Recurrence ; Research Design/trends ; Tomography, X-Ray Computed
    Language English
    Publishing date 2009-12-14
    Publishing country England
    Document type Letter
    ISSN 1471-230X
    ISSN (online) 1471-230X
    DOI 10.1186/1471-230X-9-93
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Pancreatic resection for pancreatic cancer.

    Bachmann, Jeannine / Michalski, Christoph W / Martignoni, Marc E / Büchler, Markus W / Friess, Helmut

    HPB : the official journal of the International Hepato Pancreato Biliary Association

    2008  Volume 8, Issue 5, Page(s) 346–351

    Language English
    Publishing date 2008-03-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 2131251-5
    ISSN 1365-182X
    ISSN 1365-182X
    DOI 10.1080/13651820600803981
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Cachexia worsens prognosis in patients with resectable pancreatic cancer.

    Bachmann, Jeannine / Heiligensetzer, Mathias / Krakowski-Roosen, Holger / Büchler, Markus W / Friess, Helmut / Martignoni, Marc E

    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

    2008  Volume 12, Issue 7, Page(s) 1193–1201

    Abstract: Introduction: Pancreatic cancer is the fourth leading cause of cancer-related death in Western countries with a poor prognosis (5-year survival rates, 25% in patients after tumor resection with adjuvant treatment; overall, the 5-year survival rate is ... ...

    Abstract Introduction: Pancreatic cancer is the fourth leading cause of cancer-related death in Western countries with a poor prognosis (5-year survival rates, 25% in patients after tumor resection with adjuvant treatment; overall, the 5-year survival rate is about 4%; Jemal et al., CA Cancer J Clin, 55:10-30, 2005). Many patients develop a cachectic status during the progression of the disease, and this syndrome accounts for up to 80% of deaths in patients with advanced pancreatic cancer. Remarkably, there are only a few data available on the impact of cachexia in patients with pancreatic cancer scheduled for tumor resection.
    Material and methods: Therefore, in this study, 227 consecutive patients with ductal adenocarcinoma of the pancreas were documented over an 18-month period regarding the prevalence of cachexia and its influence on perioperative morbidity and mortality with a special interest to postoperative weight gain and survival in a prospectively designed database and followed up.
    Results: In 40.5% of the patients, cachexia was already present at the time of operation. The cachectic patients did present in a worse nutritional status, represented by lower protein, albumins, and hemoglobin levels. Despite no significant differences in tumor size, lymph node status, and CA19-9 levels, the resection rate in patients with cachexia was reduced (77.8% vs. 48.9%) due to a higher rate of metastatic disease in patients with cachexia. The morbidity and in-hospital mortality revealed no significant difference. However, patients with and without cachexia lost weight after operation, and the weight gain started not until 6 months after operation. The survival in patients with cachexia was significantly reduced in patients undergoing tumor resection as well as in palliative treated patients.
    Conclusion: Cachexia has a significant impact on survival and performance status in palliative patients as well as in patients operated for pancreatic cancer. But tumor-related cachexia is not necessarily dependent on tumor size or load and that metastatic dedifferentiation of the tumor might be a critical step in the development of tumor-associated cachexia.
    MeSH term(s) Aged ; Body Weight ; Cachexia/epidemiology ; Cachexia/etiology ; Cachexia/therapy ; Carcinoma, Pancreatic Ductal/complications ; Carcinoma, Pancreatic Ductal/pathology ; Carcinoma, Pancreatic Ductal/surgery ; Female ; Follow-Up Studies ; Germany/epidemiology ; Humans ; Incidence ; Male ; Middle Aged ; Neoplasm Staging ; Nutritional Support/methods ; Pancreatectomy/methods ; Pancreatic Neoplasms/complications ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/surgery ; Postoperative Care/methods ; Prognosis ; Retrospective Studies ; Survival Rate
    Language English
    Publishing date 2008-03-18
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 2012365-6
    ISSN 1873-4626 ; 1934-3213 ; 1091-255X
    ISSN (online) 1873-4626 ; 1934-3213
    ISSN 1091-255X
    DOI 10.1007/s11605-008-0505-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top